Axios

Moderna and Merck shares soar on mRNA cancer vaccine

Moderna and Merck shares soared on Wednesday after the companies said a personalized mRNA treatment hit its target of preventing skin cancer from recurring or spreading in a late-stage clinical trial. Why it matters: The results come at a pivotal moment for Moderna and mRNA research, after

作者 Axios

1 分钟阅读
Moderna and Merck shares soar on mRNA cancer vaccine
Moderna and Merck shares soar on mRNA cancer vaccine

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Business & Leadership相关内容

相关洞察